Pregnancy & MTCT
Pregnancy & HIV MTCT
BHIVA 2017: Despite Reassuring Data, We Can’t Yet Say U=U for Breastfeeding
- Details
- Category: Pregnancy & HIV MTCT
- Published on Thursday, 30 November 2017 00:00
- Written by Roger Pebody
While effective HIV treatment greatly reduces the risk of onward transmission during breastfeeding, it does not appear that the risk is zero, a leading pediatrician told the British HIV Association (BHIVA) conference last month in London last week.
HR17: Combining Drug Addiction Treatment and Perinatal HIV Prevention Leads to Good Outcomes
- Details
- Category: Pregnancy & HIV MTCT
- Published on Wednesday, 31 May 2017 00:00
- Written by Liz Highleyman
An integrated program offering medication-assisted drug addiction treatment and services aimed at preventing mother-to-child HIV transmission led to improved outcomes for opioid-dependent HIV-positive mothers and their babies, according to a presentation at the 25th Harm Reduction International Conference this month in Montreal.
AIDS 2016: Study Looks at Use of HIV PrEP Before and During Pregnancy and Breastfeeding
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Thursday, 25 August 2016 00:00
- Written by Liz Highleyman
Truvada for pre-exposure prophylaxis (PrEP) when it was offered as an additional tool for preventing HIV infection during the pre-conception period, pregnancy, and breastfeeding, according to study findings presented at the 21st International AIDS Conference (AIDS 2016) last month in Durban and published in the July 19 online edition of the American Journal of Obstetrics and Gynecology.
CROI 2017: Efavirenz/ Tenofovir/Emtricitabine Less Likely to Cause Adverse Birth Outcomes
- Details
- Category: Pregnancy & HIV MTCT
- Published on Tuesday, 21 February 2017 00:00
- Written by Carole Leach-Lemens
Infants exposed to an antiretroviral regimen of tenofovir, emtricitabine, and efavirenz (Atripla) from conception experienced fewer adverse birth outcomes compared to those exposed to other 3-drug regimens, according to a study of births in Botswana presented at the 2017 Conference on Retroviruses and Opportunistic Infections (CROI) last week in Seattle.
AIDS 2016: Early HIV Treatment -- Mothers Say They Need Time to Think
- Details
- Category: HIV Treatment
- Published on Thursday, 28 July 2016 00:00
- Written by Carole Leach-Lemens
Findings from the first randomized controlled trial to date evaluating postpartum antiretroviral therapy (ART) for women with high CD4 cell counts (over 400 cells/mm3) highlight a critical need to increase treatment acceptance in this population, according to research presented at the 21st International AIDS Conference (AIDS 2016) last week in Durban.
More Articles...
- AIDS 2016: South Africa Has Driven Mother-to-Child HIV Transmission Down to 4%
- CROI 2016: Studies Probe Retention in Care for HIV+ Women Who Start ART During Pregnancy
- CROI 2016: Cotrimoxazole Prophylaxis Provides No Benefit for HIV-Exposed Uninfected Children
- CROI 2016: Option B+ Cuts Mother-to-Child HIV Transmission Dramatically in Malawi
Web Design and Development by